SCHEMBL16617396

SCHEMBL16617396

[N-]=[N+]=NC(C(=O)C1CCC(F)(F)CC1C(=O)O)c1ccc(C(=O)N2CCOCC2)cc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.38
HPGD P15428 3/20 0.37
HSD11B1 P28845 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
PHGDH O43175 1/20 0.36
EPHX2 P34913 1/20 0.36
TSHR P16473 2/20 0.35
MLYCD O95822 1/20 0.35
L3MBTL3 Q96JM7 1/20 0.35
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.34
AKR1C3 P42330 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16618170 0.90 ALDH1A1 (0.38) POLBHPGDHSD11B1L3MBTL1ALDH1A1
SCHEMBL16618171 0.90 ALDH1A1 (0.38) POLBHPGDHSD11B1L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL16617816 0.84 HPGD (0.40) POLBHPGDL3MBTL1ALDH1A1KMT2A
SCHEMBL16617401 0.83 HSD11B1 (0.37) POLBHPGDHSD11B1L3MBTL1ALDH1A1
SCHEMBL16617338 0.83 HPGD (0.41) POLBHPGDL3MBTL1ALDH1A1KMT2A
SCHEMBL16617541 0.75 ABL1 (0.45) POLBHPGDL3MBTL1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL16617133 0.74 KMT2A (0.41) POLBHPGDHSD11B1L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL16617132 0.74 KMT2A (0.41) POLBHPGDHSD11B1L3MBTL1ALDH1A1
SCHEMBL16617855 0.73 ALDH1A1 (0.41) POLBHPGDHSD11B1L3MBTL1ALDH1A1
SCHEMBL16617856 0.73 ALDH1A1 (0.41) POLBHPGDHSD11B1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3055314-B1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME (US) 2018-09-12 EP disclosed
US-9458181-B2 Cathepsin cysteine protease inhibitors MERCK SHARP & DOHME CORP. (US) 2016-10-04 US disclosed
EP-3055314-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2016-08-17 EP disclosed
WO-2015054089-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-04-16 WO disclosed
US-20150099719-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099719-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS CTSB, CTSS, CTSZ POLB 3196/4885HPGD 3020/4885HSD11B1 3188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.